The study also proposed that CABLES1 mutations could represent a novel pituitary tumor-predisposing mechanism, particularly affecting interactions with cyclin-dependent kinases (CDKs) and the epidermal growth factor receptor (EGFR) pathway [53]. This evidence concerns the gene EGFR and pituitary tumor.